1. Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial. Issue 3 (March 2015) Authors: Rizvi, Naiyer A; Mazières, Julien; Planchard, David; Stinchcombe, Thomas E; Dy, Grace K; Antonia, Scott J; Horn, Leora; Lena, Hervé; Minenza, Elisa; Mennecier, Bertrand; Otterson, Gregory A; Campos, Luis T; Gandara, David R; Levy, Benjamin P; Nair, Suresh G; Zalcman, Gérard; Wolf, Jürgen; Souquet... Journal: Lancet oncology Issue: Volume 16:Issue 3(2015:Mar.) Page Start: 257 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial. Issue 3 (March 2015) Authors: Rizvi, Naiyer A; Mazières, Julien; Planchard, David; Stinchcombe, Thomas E; Dy, Grace K; Antonia, Scott J; Horn, Leora; Lena, Hervé; Minenza, Elisa; Mennecier, Bertrand; Otterson, Gregory A; Campos, Luis T; Gandara, David R; Levy, Benjamin P; Nair, Suresh G; Zalcman, Gérard; Wolf, Jürgen; Souquet... Journal: Lancet oncology Issue: Volume 16:Issue 3(2015:Mar.) Page Start: 257 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1–2 trials. Issue 2 (February 2020) Authors: Drilon, Alexander; Siena, Salvatore; Dziadziuszko, Rafal; Barlesi, Fabrice; Krebs, Matthew G; Shaw, Alice T; de Braud, Filippo; Rolfo, Christian; Ahn, Myung-Ju; Wolf, Jürgen; Seto, Takashi; Cho, Byoung Chul; Patel, Manish R; Chiu, Chao-Hua; John, Thomas; Goto, Koichi; Karapetis, Christos S; Arken... Journal: Lancet oncology Issue: Volume 21:Issue 2(2020) Page Start: 261 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Four-year survival with nivolumab in patients with previously treated advanced non-small-cell lung cancer: a pooled analysis. Issue 10 (October 2019) Authors: Antonia, Scott J; Borghaei, Hossein; Ramalingam, Suresh S; Horn, Leora; De Castro Carpeño, Javier; Pluzanski, Adam; Burgio, Marco A; Garassino, Marina; Chow, Laura Q M; Gettinger, Scott; Crinò, Lucio; Planchard, David; Butts, Charles; Drilon, Alexander; Wojcik-Tomaszewska, Joanna; Otterson, Grego... Journal: Lancet oncology Issue: Volume 20:Issue 10(2019) Page Start: 1395 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Research Highlights. (May 2012) Authors: Wu, Yun; Duan, Wenrui; Otterson, Gregory A; Lee, L James; Nana-Sinkam, S Patrick Journal: Personalized medicine Issue: Volume 9:Number 3(2012) Page Start: 329 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗